Migratory cells (MCs) were collected 24 h post-infection and washed 5 × with RPMI medium containing 10 % fetal calf serum. This MC fraction was termed MC1. At the same time, each tissue explant was extensively washed (5 × ) to remove the inoculum. Cervico-vaginal explants were further maintained in cell culture medium for 7 days and additional MC fractions were collected on days 3 and 7 post-infection. Equal numbers of MC1, MC3, and MC7 were incubated with GHOST.X4, GHOST.R5, and PHA / IL-2-stimulated PBMCs. Virus replication was measured in culture supernatant at day 7 of co-incubation, using a Gag p24 antigen detection enzyme-linked immunosorbent assay (ELISA). Figure 1a ). Gag p24 levels were measured 7 days after onset of coculture. MCs appeared to efficiently disseminate both R5 and X4 variants to activated PBMC both in mono-and dual infections ( Figure 1b and c ) . As expected, MCs carrying R5 HIV-1 or X4 HIV-1 were able to disseminate virus almost exclusively to GHOST.R5 or GHOST. X4 cells, respectively. Interestingly, dual infections / competitions with R5 and X4 biological clones from the same patient showed that both clones are transferred efficiently from MCs to GHOST. R5, GHOST.X4, and PBMCs. This observation was performed with eight biological clones from three different HIV + patients in three independent tissue donors. In contrast to the results published by Saba et al. , 1 showing that the X4 LAI virus does not replicate in cervico-vaginal tissue, our findings suggest that both R5-and X4-tropic HIV-1 can infect MCs in cervico-vaginal tissue and that both can efficiently be transferred onto other HIV target cells (e.g., T cells).
Seminal work by Hu et al. 4 showed that the MC fraction from cervico-vaginal tissue roughly consists of CD3 − HLA-DR + (i.e., DC-SIGN + DC) and CD3 + HLA-DR − cells (i.e., T cells) that emigrate out of the explant in two phases. While the number of emigrating lymphocytes increased over time, the majority of DC migrated quickly within the first 24 h and carried most of the infectious HIV. It is well established that DC can transfer HIV to T cells bo th in trans and in cis . We have collected MC fractions at 1, 3, and 7 days post-inoculation and found consistently that both R5 and X4 viruses were efficiently transferred to PHAactivated T lymphocytes. Although it is still unclear how long DCs can retain HIV in an infectious state in the absence of productive infection, this process is supposed to last somewhere between hours and 2 -3 days. 5 Although our observation with MC from days 1 and 3 may result from virus retained by DC and transfer to PHA-activated T lymphocytes, the results with day 7 MC strongly suggest that productive infection of DC and / or T lymphocytes within the MC also occurs. This observation is in line with recent evidence showing focal infected founder populations of cells (DCs and T lymphocytes) in the endocervix. 6 Altogether, our observations suggest that other mechanisms than coreceptor expression at the cervico-vaginal site are underlying the " gatekeeping " mechanism upon sexual HIV transmission. To the Editor: The exclusive ability of HIV-1 R5 (not HIV-1 X4 ) to transmit infec tion in vivo suggests the existence of " gatekeeping " mechanisms that select one HIV variant over the other. In response to our paper, 1 which showed that human cervico-vaginal tissue ex vivo preferentially supports the productive infection of HIV-1 R5 rather than that of HIV-1 X4 , Ari ë n et al. 2 report that cervico-vaginal migratory cells (MCs) are able to transfer equally both HIV-1 R5 and HIV-1 X4 to CD4-CCR5-and CD4-CXR4-transfected osteosarcoma cell lines and to activated peripheral blood mononuclear cells. Ari ë n et al. concluded that, " in contrast " with our results, their " findings suggest that both HIV-1 R5 and HIV-1 X4 can infect MCs and be transferred onto other HIV-1 target cells " .
We think that the results of our two groups are complementary rather than contradictory: the fact that HIV-1 R5 replicates more efficiently than HIV-1 X4 in cervico-vaginal tissue does not contradict the evidence that both infectious HIV-1 X4 and HIV-1 R5 virions can be retained by inoculated tissue in or on dendritic
